Evidence map›Paper›PMID 18391028›Full record

ArticleAntimicrobial agents and chemotherapy2008

Increasing incidence of linezolid-intermediate or -resistant, vancomycin-resistant Enterococcus faecium strains parallels increasing linezolid consumption.

Marc H Scheetz, Stephanie A Knechtel, Michael Malczynski, Michael J Postelnick, Chao Qi

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 90 citations in OpenAlex.

  1. Vancomycin-ResistantAntibiotics (Basel, Switzerland) · 2025
    Review
  2. Article
  3. Metabolic Rewiring ofMetabolites · 2024
    Review
  4. Review
  5. Treatment ofAntibiotics (Basel, Switzerland) · 2023
    Review
  6. Article
  7. Linezolid-resistantJournal of family medicine and primary care · 2019
    Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Marc H ScheetzMidwestern University Chicago College of Pharmacy, Infectious Diseases Pharmacist, Northwestern Memorial Hospital, 251 E. Huron St., Feinberg Pavilion LC-700, Chicago, IL 60611, USA. mscheetz@nmh.org
Stephanie A Knechtel
Michael Malczynski
Michael J Postelnick
Chao Qi
Northwestern Memorial Hospital · USMidwestern University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clinical enterococcal resistance to linezolid is defined by the presence of the G2576T mutation. We evaluated the incidence of genetically proven linezolid resistance among vancomycin-resistant Enterococcus faecium strains and linezolid consumption for a possible association. A relationship was found (r(2) = 0.73, P = 0.03) and predicts increasing resistance with current trends of linezolid use.

Indexed as

Vancomycin ResistanceAcetamidesAnti-Infective AgentsDrug Resistance, BacterialEnterococcus faeciumGram-Positive Bacterial InfectionsHumansIncidenceLinezolidMolecular EpidemiologyMutationOxazolidinonesAcetamidesAnti-Infective AgentsLinezolidOxazolidinones

Identifiers

PMID18391028
PMCPMC2415807
OpenAlexW2155952514

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.